Cargando…

The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disease incurable due to late diagnosis and treatment. Therefore, one of the priorities of neurology is to study the mechanisms of PD pathogenesis at the preclinical and early clinical stages. Given the important role of sphingolipids in the pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blokhin, Victor, Shupik, Maria, Gutner, Ulyana, Pavlova, Ekaterina, Lebedev, Albert T., Maloshitskaya, Olga, Bogdanov, Vsevolod, Sokolov, Sergey, Alessenko, Alice, Ugrumov, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773707/ https://www.ncbi.nlm.nih.gov/pubmed/35053241 http://dx.doi.org/10.3390/biom12010093

Ejemplares similares

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Alessenko, Alisa V., et al.
Publicado: (2023)

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
por: Bogdanov, Vsevolod, et al.
Publicado: (2021)

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
por: Kolacheva, Anna, et al.
Publicado: (2022)

The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2023)

Sphingolipids in Inflammation
por: Albi, Elisabetta, et al.
Publicado: (2018)

A Monoiodotyrosine Challenge Test in a Parkinson’s Disease Model
por: Kim, A. R., et al.
Publicado: (2021)

Exploring Sphingolipid Implications in Neurodegeneration
por: Alessenko, Alice V., et al.
Publicado: (2020)

Compensatory Processes in Striatal Neurons Expressing the Tyrosine Hydroxylase Gene in Transgenic Mice in a Model of Parkinson’s Disease
por: Troshev, Dmitry, et al.
Publicado: (2023)

The Periventricular Nucleus as a Brain Center Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis
por: Ugrumov, Michael V., et al.
Publicado: (2022)

The Many Facets of Sphingolipids in the Specific Phases of Acute Inflammatory Response
por: Grösch, Sabine, et al.
Publicado: (2018)

A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors
por: Kolacheva, A. A., et al.
Publicado: (2021)

Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
por: Katunina, Elena A., et al.
Publicado: (2023)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
por: Du, Guangwei, et al.
Publicado: (2012)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease()
por: Ziegler, Erik, et al.
Publicado: (2014)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson’s Disease
por: Wilkinson, Hayden, et al.
Publicado: (2021)

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016)

Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats☆
por: Zhou, Qingwei, et al.
Publicado: (2012)

Development of the Periventricular Nucleus as a Brain Center, Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis
por: Pronina, Tatiana, et al.
Publicado: (2022)

Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014)

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism
por: Chang, Chiung-Chih, et al.
Publicado: (2016)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
por: Caminiti, Silvia Paola, et al.
Publicado: (2017)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
por: Wang, Jing, et al.
Publicado: (2020)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson’s disease
por: Tang, Lei, et al.
Publicado: (2023)

Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research
por: Troshev, Dmitry, et al.
Publicado: (2022)

Development of early diagnosis of Parkinson's disease: Illusion or reality?
por: Ugrumov, Michael
Publicado: (2020)

Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease
por: Vernon, Anthony C, et al.
Publicado: (2010)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2011)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
por: López-Aguirre, M., et al.
Publicado: (2023)

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
por: Hinkle, Jared T., et al.
Publicado: (2022)

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
por: Perlbarg, Vincent, et al.
Publicado: (2018)

3433 Tissue Engineered Nigrostriatal Pathway as a Test-Bed for Evaluating Axonal Pathophysiology in Parkinson’s disease
por: Clark, Elisia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_242mafpeuv7oodv1ga47upr3pj